# Neuronostatin - a Glucagonotropic Agent in Humans?

> **NCT06143267** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia
- Type1diabetes

## Interventions

- **OTHER:** Infusion of either NST or placebo at different blood glucose levels

## Key facts

- **NCT ID:** NCT06143267
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-06
- **Primary completion:** 2024-09-25
- **Final completion:** 2024-09-25
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143267, "Neuronostatin - a Glucagonotropic Agent in Humans?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06143267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*